Invitation to presentation of Acarix´s first quarter report
Acarix will publish its first quarter results on Tuesday 14 May 2024 at 08.00 am (CEST). A live webcast will be held at 15.00 (CEST) th...
CADScor System is now being utilized by Leading Cardiology Practice in the New York Capital Region
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the integration of the CADScor System at Capital Cardiology ...
Proposal by the nomination committee prior to the 2024 annual general meeting of Acarix AB (publ)
The Nomination Committee of Acarix consists of Jan Poulsen (Chairman) representing Life Science Invest Fund 1 among others, Anton Rehns...
Acarix receives order from the first freestanding Emergency Room in the US
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the CADScor System has been added to the diagnostic tools av...
Acarix announces the initiation of the first US-based clinical workflow evaluation study
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces the initiation of the first US-based clinical study to colle...
Acarix inleder klinisk utvärderingsstudie hos University of California
Acarix, ledande inom avancerad akustikbaserad hjärtdiagnostik, tillkännager idag uppstarten av den första kliniska studien i USA i syft...
Acarix adopts new growth-focused business model and provides outlook update as part of our ongoing strategic review
Acarix, a leader in advanced acoustic- and algorithm-based cardiac diagnostics, announces the adoption of a new innovative usage-based ...
Acarix antar ny tillväxtfokuserad affärsmodell och ger en uppdatering av strategiska och finansiella mål
Acarix, ledande aktör inom akustik- och algoritmbaserad hjärtdiagnostik, tillkännager idag införandet av en ny innovativ användarbasera...
New Health Economic Analysis Presented at ACC Highlights The Acarix CADScor System’s Cost-Effectiveness
Acarix, a leader in acoustic-based Cardiac Diagnostics, is pleased to announce the results from a 2024 American College of Cardiology (...
Ny hälsoekonomisk analys presenterad på ACC styrker kostnadseffektiviteten i Acarix CADScor System
Acarix, ledande aktör inom akustiskbaserad hjärtdiagnostik, tillkännager idag resultaten från en presentation på årets American College...
Acarix lämnar in ansökan om handel av bolagets aktie på OTCQB-marknaden i USA
New York, New York, 5 april 2024 – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, meddelar idag inlämnandet av en ...
Acarix has submitted application for cross-trading at OTCQB in the US
New York, New York, April 5, 2024 – Acarix, a leader in advanced acoustic-based cardiac diagnostics announces the submission of an appl...